Singlife Launches Insurer-Led Chronic Care Programme for Weight…

Event summary

Singlife has launched Singapore's first insurer-led chronic care programme for weight management in partnership with Novo Nordisk Singapore and HMI Medical.
The programme offers medically guided weight management, including medical consultations and prescription treatments, for S$289 per month.
The initiative targets adults with a BMI of at least 30 kg/m² or between 27 and below 30 kg/m² with at least one weight-related comorbidity.
Improvements in weight and overall health will be considered in Singlife's underwriting assessments for new policies or policy reviews.
Obesity prevalence in Singapore rose from 10.5% in 2019–2020 to 12.7% in 2023–2024.

The big picture

Singlife's initiative marks a strategic shift towards preventive care in the insurance sector, aligning with broader industry trends of integrating healthcare and financial services. The partnership with Novo Nordisk and HMI Medical leverages expertise in obesity care and healthcare delivery to address a growing health concern in Singapore. With over S$16 billion in assets, Singlife's move underscores the potential for insurers to play a proactive role in managing chronic conditions and reducing long-term healthcare costs.

What we're watching

Programme Adoption: The pace at which Singlife customers enroll in the chronic care programme will indicate the demand for insurer-led weight management solutions.
Health Outcomes: Whether the programme successfully improves health outcomes and reduces the risk of chronic diseases among participants.
Underwriting Impact: How improvements in weight and overall health influence Singlife's underwriting assessments and policy reviews.